When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BIOVF - European advisory group backs SOBI's Gilead's Doptelet in thrombocytopenia
Swedish Orphan Biovit Ord
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval for Swedish Orphan Biovitrum's or SOBI (BIOVF) Doptelet (avatrombopag) for the treatment of primary chronic immune thrombocytopenia, an autoimmune disorder characterised by low numbers of platelets, in adult patients who are refractory to other treatments.A final decision from the European Commission usually takes ~60 days.